Cedar Capital LLC cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 844 shares of the medical equipment provider’s stock after selling 43 shares during the quarter. Cedar Capital LLC’s holdings in Intuitive Surgical were worth $482,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors also recently made changes to their positions in the company. Stone House Investment Management LLC bought a new stake in Intuitive Surgical during the first quarter valued at approximately $31,000. Laurel Wealth Advisors LLC bought a new stake in Intuitive Surgical during the fourth quarter valued at approximately $32,000. Athena Capital Advisors LLC bought a new stake in Intuitive Surgical during the fourth quarter valued at approximately $33,000. Financial Advantage Inc. bought a new stake in Intuitive Surgical during the fourth quarter valued at approximately $36,000. Finally, Harvest Group Wealth Management LLC bought a new stake in Intuitive Surgical during the first quarter valued at approximately $44,000. Institutional investors and hedge funds own 84.85% of the company’s stock.
Shares of Intuitive Surgical stock opened at $491.73 on Friday. The firm has a market cap of $56.47 billion, a price-to-earnings ratio of 51.82, a P/E/G ratio of 4.27 and a beta of 1.02. Intuitive Surgical, Inc. has a 12-month low of $430.24 and a 12-month high of $589.32.
Several brokerages have issued reports on ISRG. BidaskClub lowered shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, April 16th. Zacks Investment Research upgraded shares of Intuitive Surgical from a “sell” rating to a “hold” rating in a research report on Wednesday, April 17th. Citigroup dropped their target price on shares of Intuitive Surgical from $611.00 to $575.00 and set a “buy” rating for the company in a research report on Tuesday. BTIG Research reaffirmed a “hold” rating on shares of Intuitive Surgical in a research note on Sunday, April 21st. Finally, Canaccord Genuity reaffirmed a “buy” rating and issued a $575.00 target price (down from $610.00) on shares of Intuitive Surgical in a research note on Monday, April 22nd. Two research analysts have rated the stock with a sell rating, four have given a hold rating and fourteen have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $576.82.
In other Intuitive Surgical news, CEO Gary S. Guthart sold 22,636 shares of the business’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $501.48, for a total transaction of $11,351,501.28. Following the transaction, the chief executive officer now directly owns 386,866 shares of the company’s stock, valued at approximately $194,005,561.68. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Jamie Samath sold 260 shares of the business’s stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $500.00, for a total transaction of $130,000.00. Following the transaction, the vice president now directly owns 278 shares in the company, valued at $139,000. The disclosure for this sale can be found here. Over the last three months, insiders have sold 32,266 shares of company stock worth $16,451,271. Insiders own 1.70% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.